The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED) "RED-CABG"


Phase 3 Results

Summary of Purpose

The purpose of this study is to determine whether acadesine is effective in reducing the cardiovascular and cerebrovascular adverse events in high-risk participants undergoing CABG surgery.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 October 2015.

1 Apr 2009 27 Mar 2009 1 Oct 2010 1 Oct 2010 1 Oct 2015 20 Nov 2012
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment


Not available